Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy, safety and tolerability of two dosing schedules of
LDE225 in patients with relapsed/refractory acute leukemia or elderly patients with untreated
acute leukemia.